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Blood Pressure Indices and Cardiovascular Disease
in the Asia Pacific Region
A Pooled Analysis
Asia Pacific Cohort Studies Collaboration
Abstract—This article aims to compare the importance of systolic blood pressure (SBP), diastolic blood pressure (DBP),
mean arterial pressure (MAP), and pulse pressure (PP) as risk factors for stroke and ischemic heart disease and to assess
whether the patterns are consistent by age and gender. Cox proportional-hazards regression, adjusted for cholesterol and
smoking, was used to assess the associations of the 4 BP indices with stroke and ischemic heart disease by age and
gender. The relative importance of individual indices was assessed with a hazard ratios for a 1-SD change in BP and
by likelihood-ratio 2 tests. The influence of 1 BP index in the Cox model was also estimated. The analyses
demonstrated similar associations of SBP, DBP, and MAP with both fatal stroke and ischemic heart diseases, which
were stronger than those of PP. Both SBP and MAP tended to be more important in the regression model than DBP or
PP. In Cox models including DBP, addition of SBP improved the goodness of fit at all ages and for both genders.
However, in Cox models including SBP, addition of DBP typically resulted in little incremental benefit over and above
that of SBP alone. These data suggest that if time or resources are highly constrained, such as in much-needed
epidemiologic surveys in developing countries, very little is lost from only measuring SBP. (Hypertension. 2003;42:
69-75.)
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Blood pressure (BP) is an important risk factor for cardio-vascular disease, and it is a key component of any formula
that predicts cardiovascular risk.1–4 However, uncertainties re-
main over which BP indices, systolic blood pressure (SBP),
diastolic blood pressure (DBP), mean arterial pressure (MAP),
or pulse pressure (PP), are the most important risk factors for a
cardiovascular event.
In the past, greater emphasis was always placed on DBP than
SBP, because elevation of the former variable was thought to
confer greater risk for cardiovascular disease than elevated
SBP.5,6 Data from the Framingham study, published 30 years
ago, demonstrated that this was not the case,7,8 and most
guidelines now include both indices.9,10 More recently, attention
has also focused on the role of MAP and PP in cardiovascular
disease,11–15 and several analyses using different methodologies
have explored the relative importance of all 4 BP indices. The
majority of analyses have demonstrated that the association
between SBP and cardiovascular disease is stronger than that of
DBP in most age and gender groups.11–14 16–18 Neither MAP nor
PP has been shown to be conclusively superior to
SBP.11,12,14,15,18,19 Data from a large number of cohort studies
have demonstrated that the relative magnitude of the association
between SBP and DBP and cardiovascular disease differs by
age.20,21 Several analyses have also suggested that the relative
importance of BP indices may change with age and that DBP
could be more important in those aged50 years,14,18,22 but this
finding is not consistent.13,16,17 Most analyses have not compared
the BP indices by gender, and most have been based on North
American or European populations.
Data from the Asia Pacific Cohort Studies Collaboration
(APCSC) presented an ideal opportunity to compare all 4 BP
indices for both fatal stroke and ischemic heart disease (IHD).
This dataset has considerable follow-up data, which allowed
analyses to assess whether the importance of BP indices varied
by age, gender, and cardiovascular end point. Analyses of data
from Asia, Australia, and New Zealand determined whether
patterns in these populations were similar to those previously
documented in predominantly European and North American
studies. Secondary analyses were able to determine the influence
of a combination of BP indices. This information will help
clarify the relative importance of BP indices, and it also has the
potential to contribute to better risk prediction.
Methods
Study Sample
The methods of study identification for the APCSC have been
reported elsewhere.23 In brief, prospective cohort studies were
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eligible for inclusion if they included study populations from the
Asia Pacific region with at least 5000 person-years of follow-up
recorded or planned. They had to have recorded data on date of birth
or age, gender, BP at baseline, and age at death. Additional data
sought included date of the baseline survey, total blood cholesterol,
diabetes, height, weight, smoking habit, and any data on repeated
measures of risk factors. Outcome data included stroke and IHD.23
Data from a total of 37 cohort studies have been collated to date.
Statistical Methods
Primary analyses assessed the relation of individual BP indices to
cardiovascular end points. MAP was calculated as 2/3 DBP1/3
SBP, and PP as SBPDBP. The analyses were performed on
“one-off” measures (ie, taken at one point in time only) of BP, which
are appropriate in a clinical setting. They were not adjusted for
regression dilution bias.24 Because several different cohort studies
were included, potential statistical heterogeneity was taken into
account by stratifying by cohort. Additional effect modification was
assessed with the use of statistical interaction terms for age and
gender. When there was evidence of effect modification, analyses
were stratified into the relevant subgroups. Cox proportional-hazards
analyses25 were then used to regress time until first event against
baseline BP with individual participant data collected in all cohorts.
Analyses were undertaken for total (fatal and nonfatal) and fatal
events separately and were also performed separately for 2 end
points: stroke and IHD. Fatal events were defined as death occurring
within 28 days after the stroke or IHD event; additional data on
disease end points has been published elsewhere.23 Each BP index
was considered separately as a continuous variable in the Cox
regression. Regression coefficients and SEs were calculated with and
without adjusting for cholesterol and smoking. Serum total choles-
terol was fitted as a continuous variable (mmol/L), and smoking
status was categorical (never vs ever smoked).
To compare the association of different BP indices with a
particular end point, hazard ratios and 95% confidence intervals
(CIs) were estimated for a 1-SD difference in each index. This is a
“standardized” comparison of hazard ratios and is necessary because
each BP index is measured on a different scale. The likelihood ratio
2 was used as a measure of the improvement of goodness of fit,26 or
“informativeness,” between a model containing each BP index (and
the confounders smoking and cholesterol) compared with a model
that only contained the confounders but no BP index (the “base
model”) by age and gender.
Because some of the 37 cohorts in the collaboration included
different age and gender subgroups, only a subset of cohorts is
included in this report. This was done because one of the aims of the
current analysis was to assess whether the relative importance of BP
indices varied by age and gender. Comparisons of BP indices by
using likelihood-ratio 2 across age and gender subgroups are valid
only if the regression models for males, females, and different age
groups are nested within each other. This means that they must be
based on the same participants, and thus, restriction of studies was
necessary. Inclusion of studies that did not contribute to all age-
gender subgroups would have made age and gender comparisons
invalid, because it would not have been possible to determine
whether patterns with age and gender were real or artifactual due to
missing data. In total, a subset of 16 cohort studies included
participants of both genders with age groups ranging from50 years
to 70 years and with data on BP, cholesterol, and smoking status.
Participants with complete data from these 16 studies were used for
the purposes of these analyses.
Secondary analyses consisted of including 2 BP indices in the Cox
proportional-hazards model to assess the relation simultaneously
with adjustment for each other. The likelihood-ratio 2 test between
the model containing a single BP index and the model containing1
index was used to assess whether the additional index significantly
improved the adequacy of the model. A significant likelihood-ratio
2 indicates that the regression coefficient of the additional index is
significant compared with zero;26,27 ie, the index provides signifi-
cantly more information. If the 2 BP indices are highly correlated,
then collinearity might become a problem. When considering the
joint effects of SBP and DBP, we assessed collinearity by inspecting
the changes in the coefficient and SE of SBP caused by the addition
of DBP and vice versa. Large changes in either the parameter
estimate or SE are indicative of collinearity.28
Results
Study Sample
Data from 16 cohort studies, which included 94 147 partici-
pants and 799 000 person-years of follow-up, were in-
cluded in these analyses (Table 1). There were 3 cohorts from
mainland China (13% of participants), 8 from Japan (17%), 1
from Taiwan (6%), 3 from Australia (61%), and 1 from New
Zealand (3%). The mean age of participants at baseline was
52 years, and 54% of participants were female. During a
mean follow-up of 8.5 years, a total of 1814 strokes (1120
fatal) and 1677 IHD events (1312 fatal) were recorded.
Investigating a Single BP Index
When the interaction terms for age and gender were intro-
duced into the model, there were significant (P0.05) differ-
ences between some of these subgroups, suggesting that there
was an effect modification by age and gender. This effect
modification was also evident in previous BP analyses of all
APCSC cohorts.21 Therefore, all further analyses were per-
formed by age (classified as50, 50 to 59, 60 to 69, and70
years) and gender. Analyses were carried out separately by
country, and there were no consistent differences between
countries. Country-specific results were also consistent with
analyses of the overall group, which are presented in this
article. (For example, in 60- to 69-year-old women, the
association between BP and stroke was stronger for both SBP
and MAP compared with DBP and PP across all countries.) In
addition, separate analyses were performed that excluded
participants who had a history of cardiovascular disease (for
those studies that provided this information) and on several
large APCSC cohorts excluded from the main analyses, and
similar patterns were evident to those presented later. The
difference between adjusted hazard ratios and those that were
unadjusted for cholesterol and smoking was negligible, so
adjusted analyses are presented.
Stroke
Analyses that were adjusted for cholesterol and smoking
demonstrated that the association between each BP index and
fatal stroke events was log-linear and positive and that the
association was significant for most age and gender sub-
groups (Figure 1). The association between any given BP
index and stroke was stronger in the youngest age groups; ie,
the association was attenuated with age for males and
females. The associations were similar in magnitude for all 4
BP indices within each subgroup; however, most frequently,
the hazard ratios were highest for MAP and SBP, but the
absolute differences were small. These patterns were also
evident when analyses were performed on total stroke events.
The results of each BP index compared with the base
model by age and gender subgroups are shown in Figure 1.
Analyses demonstrated that in both males and females, SBP
tended to be more informative than DBP (the only exception
was in males aged 50 years). MAP ranked similarly to SBP
in most age groups, and one or the other of these indices was
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most informative in all of the age-gender subgroups for fatal
stroke events and total stroke events, the only exception being
males aged 70 years. In contrast, PP was typically less
important than SBP.
Ischemic Heart Disease
Adjusted analyses demonstrated that in all age groups, the
association between each of the BP indices and fatal IHD
events was log-linear and positive, but it was not statistically
TABLE 1. Characteristics of the 16 APCSC Cohorts Used for Analyses to Compare BP Indices*
Region and Study Name Start Year Sample Size Follow-Up, y Female, %
Age at Baseline, y
Mean SBP Mean DBP
Stroke Events IHD Events
Mean Range Total Fatal Total Fatal
Mainland China
Huashan 1990 1801 2.8 52 53 35–75 126 76 16 6 3 3
Seven Cities Cohorts 1987 6362 5.7 57 58 35–91 134 83 220 123 61 61
Shanghai Factory Workers 1972 3966 13.9 5 50 30–78 126 79 138 138 50 50
Japan
Aito Town 1980 1116 15.3 59 51 20–73 137 80 20 20 10 10
Hisayama 1961 1548 19.1 56 56 40–92 135 78 315 171 88 52
Konan 1987 1220 6.3 55 52 20–96 130 78 13 13 3 3
Miyama 1988 413 6.6 62 59 40–80 129 77 0 0 0 0
Ohasama 1992 1907 4.2 65 58 27–91 127 72 42 5 4 4
Saitama 1986 3615 9.6 62 55 20–94 135 80 55 55 24 24
Shibata 1977 2328 16.0 58 57 40–89 131 78 203 203 66 66
Shigaraki Town 1991 3722 3.9 59 57 29–95 132 78 13 13 3 3
Taiwan
CVDFACTS 1988 5540 6.4 56 47 20–92 118 75 29 29 12 12
Australia
Busselton 1966 7344 20.3 52 45 20–94 138 77 636 251 970 665
Melbourne 1990 41 141 5.7 59 55 27–75 138 77 32 32 161 161
Perth 1979 9729 12.5 47 45 20–90 130 81 59 59 186 186
New Zealand
Fletcher Challenge 1992 2395 4.8 22 40 20–88 124 77 23 2 36 12
Total or overall 94 147 8.5 54 52 20–96 134 78 1814 1120 1677 1312
Weighted average** 52 51 26–86 134 78
SBP indicates systolic blood pressure; DBP, diastolic blood pressure; IHD, ischemic heart disease. Total person years of follow-up: 799 366.
*Only those APCSC studies and participants that had data on blood pressure, cholesterol, and smoking (defined as never and ever) and contained participants aged
50 and 70 years were included in these analyses. **Weighted average, weighting by person years of follow-up.
Figure 1. Relation between BP and fatal
stroke events by age and gender. Haz-
ard ratios for fatal stroke events,
adjusted for cholesterol and smoking,
have been calculated for a 1-SD differ-
ence in BP for each index. Data are
stratified by age (50, 50 to 59, 60 to
69, and 70 years) and gender. Solid
squares are larger where there were
more events, because their size is pro-
portional to the inverse variance, and
horizontal lines represent 95% CIs.
Likelihood-ratio 2 statistics for fatal
stroke events have been calculated by
comparing a regression model including
a single BP index (and confounders cho-
lesterol and smoking) to the base model
(which included cholesterol and smoking
but no BP index).
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significant for all subgroups (Figure 2). Overall, the hazard
ratios were of similar magnitude for DBP, SBP, and MAP but
tended to be less for PP. This was consistent when analyses
were performed on total events. A comparison of the infor-
mation provided by each BP index in the regression model by
age and gender was undertaken as before (Figure 2). Analyses
demonstrated that SBP and MAP were more informative than
DBP and PP in most subgroups.
Joint Effects of BP Indices
In secondary analyses, SBP and DBP were simultaneously
included in the Cox models to assess whether there was
additional information provided for stroke or IHD compared
with a model including either SBP or DBP alone. The hazard
ratios and SEs for SBP and DBP were similar, regardless of
the order in which these indices were included in the model,
which is indicative of no major collinearity being present.
MAP or PP was not included in models with SBP or DBP,
because the former indices are already calculated from the
latter.
In most age and gender subgroups, there was a relatively
small change in the likelihood-ratio 2 statistic for the SBP
and DBP model compared with the SBP-alone model (“add-
ing DBP to a model with SBP”). Most of these changes were
not significant (Table 2). This indicates that DBP provided no
significant incremental contribution over and above the in-
formation provided by SBP alone. The results for younger
males (50 years) were less clear. Analyses of total stroke
and IHD events produced similar results. In contrast, com-
parison of the combined SBP and DBP model to the DBP-
only model (“adding SBP to a model with DBP”) produced
significant (P0.05) changes in the likelihood-ratio 2 statis-
tic for most age-gender subgroups. This indicates a signifi-
cant contribution of SBP over and above that for DBP in these
subgroups.
Discussion
These analyses clarify the impact of different BP indices as
cardiovascular risk factors in the Asia Pacific region.
Whereas the hazard ratios were of similar magnitude for all
indices, the associations were typically stronger for SBP,
DBP, and MAP than for PP, particularly in those aged 50
years. Cox models including a single BP index indicated that
SBP or MAP provided more information than those including
DBP or PP. Analyses also demonstrated broadly similar
patterns for males and females, total and fatal events, and
stroke and IHD end points. There was, however, attenuation
of the association between all BP indices and cardiovascular
disease end points with age. In those 50 years of age, the
joint effect of SBP and DBP in the Cox model typically
resulted in little incremental benefit over and above that of
SBP alone. The converse was not true; inclusion of SBP in
the Cox model did typically provide additional information
over and above that provided by DBP alone.
The finding that overall SBP appears to be statistically
more important than DBP in this “Asia Pacific” population is
consistent with results from analyses of European and North
American populations.11–13,16,17 Several analyses have con-
cluded that DBP is superior to SBP in those aged 50
years.14,15,18,22 This was not completely borne out in the
current study, but the results suggest that SBP and DBP may
be of similar importance in the youngest age groups. Many
authors have suggested that PP is an important predictor of
cardiovascular disease,11,12,19,29 possibly more so than other
BP measures. However, previous analyses frequently com-
pared the hazard ratio for a 10–mm Hg change in each BP
index.11,12,19,29 This comparison is dubious, because each
index has a different scale; therefore, a 10 mm Hg change in
one index is not comparable to a 10 mm Hg change in
another. The current analyses standardized the comparison of
hazard ratios by using a 1-SD difference in BP, which
equated to 22 mm Hg SBP and 12 mm Hg DBP. In
addition, several of the earlier analyses only included MAP
and PP but did not include a comparison between PP and
SBP.11,19,29 Our results are consistent with another recent
analysis that used a similar methodology, which also con-
cluded that the associations of SBP and MAP to cardiovas-
cular disease were stronger than those of DBP and PP.13
Figure 2. Relation between BP and fatal
IHD events by age and gender. Conven-
tions are as described in the legend to
Figure 1.
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Although we demonstrated that in most subgroups there was
little incremental benefit of including both SBP and DBP in
Cox regression models, recent analyses of Multiple Risk
Factor Intervention Trial (MRFIT) data suggested that car-
diovascular disease risk assessment was improved by consid-
ering both SBP and DBP, not just SBP or DBP alone.15
However, the current analyses were still broadly compatible,
because the MRFIT sample only included men aged 35 to 57
years at baseline, and our analyses demonstrated improved
goodness of fit with both indices in some younger subgroups.
There are some data limitations that could have influenced
the current results, such as the limited number of events in
some of the age-gender subgroups. However, even in the age
group aged 50 years, there were 128 fatal IHD events (of
269 events) and 88 fatal strokes (of 227 events). The
inclusion of a wider sample of studies from APCSC could
have limited the comparability of the age-gender subgroups,
because different cohort studies would have contributed to
different subgroups. Analyses were performed with and
without adjustment for cholesterol and smoking. However,
because of the different ways that the cohorts had recorded
smoking status, this had to be reduced to a dichotomous
variable in these analyses. Data were not available from all
cohort studies on diabetic status, electrocardiographic
changes, and history of treatment for hypertension. When the
current analyses were limited to participants without a history
of cardiovascular disease (for those cohort studies that had
provided this information), consistent results were obtained.
In addition, adjustment for the included risk factors had
negligible impact on hazard ratios, and there is no reason to
believe that information on additional risk factors would have
substantially changed the results.
These analyses were conducted on a large sample with
1800 stroke and 1600 IHD events, more than many previ-
ous analyses. Unlike several previous analyses, there was also
a high proportion of females. The current analyses were
performed on 1-off measures of BP that were not corrected
for regression dilution bias,24 but which are more commonly
TABLE 2. Increases in Goodness of Fit From Adding BP Indices to the
Regression Model, by Age, Gender, and Fatal Outcome
Change in Model by Age Group
Males Females
Likelihood
Ratio 2 P
Likelihood
Ratio 2 P
Stroke
50 years
Adding DBP to a model with SBP 24.1 0.001 0.01 0.9
Adding SBP to a model with DBP 3.6 0.06 13.4 0.001
50–59 years
Adding DBP to a model with SBP 2.3 0.1 0.1 0.8
Adding SBP to a model with DBP 36.9 0.001 12.9 0.001
60–69 years
Adding DBP to a model with SBP 2.2 0.1 0.8 0.4
Adding SBP to a model with DBP 19.9 0.001 16.2 0.001
70 years
Adding DBP to a model with SBP 1.1 0.3 0.1 0.8
Adding SBP to a model with DBP 12.7 0.001 5.8 0.01
Ischemic heart disease
50 years
Adding DBP to a model with SBP 7.8 0.005 0.03 0.9
Adding SBP to a model with DBP 4.8 0.03 16.1 0.001
50–59 years
Adding DBP to a model with SBP 2.6 0.1 3.6 0.06
Adding SBP to a model with DBP 6.5 0.01 5.2 0.02
60–69 years
Adding DBP to a model with SBP 2.1 0.2 2.1 0.2
Adding SBP to a model with DBP 25.6 0.001 20.5 0.001
70 years
Adding DBP to a model with SBP 0.1 0.7 1.1 0.3
Adding SBP to a model with DBP 1.0 0.3 3.0 0.08
This table shows increases in goodness of fit from adding DBP to a model including SBP (and also
age, gender, cholesterol, and smoking) and vice versa. The greater the likelihood ratio 2, the greater
the increase in goodness of fit or “informativeness” with the additional blood pressure index. The P
value tests the statistical significance of the change.
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available than “usual” BP. Correction for regression dilution
would have led to stronger associations between all BP
indices and end points but would not have changed the
relative comparisons of SBP and DBP.21 Estimates of the size
of the association between BP and cardiovascular disease
from all 37 studies included in APCSC have been published
elsewhere.21 In the age groups 60, 60 to 69, and 70 years,
a 10–mm Hg lower usual SBP was associated with 54%
(95% CI, 53% to 56%), 36% (34% to 38%), and 25% (22%
to 28%) lower total stroke risk and 46% (43% to 49%), 24%
(21% to 28%), and 16% (13% to 20%) lower total IHD risk,
respectively.
Overall, these analyses have demonstrated that SBP and
MAP were statistically the most important BP indices, but
DBP is still a clinically important measurement and should
not be discarded. In a clinical setting, use of SBP will be more
practical and relevant than MAP, because the former is easier
to measure and interpret.
Perspectives
In summary, this study suggests that although the hazard
ratios for all 4 BP indices are similar, SBP is statistically
more important than DBP as a risk factor for cardiovascular
disease end points in Asia Pacific populations. The patterns
were less clear for the youngest age groups; however, less of
the burden of cardiovascular disease occurs in these age
groups. This may, in part, reflect the fact that prevalent
disease and arteriosclerosis selectively reduce DBP.30,31 Ex-
cessive emphasis on PP should be avoided, because there is
no evidence that it has a stronger association with disease
than SBP. In contrast, MAP often appeared as important as
SBP. However, MAP is likely to have less clinical application
than SBP and may be less advantageous overall. SBP is
relatively simple to measure owing to a more distinct auscul-
tatory end point than DBP, and MAP requires measurement
of both SBP and DBP and a calculation. The use and
interpretation of MAP is also unlikely to be practical, because
few guidelines exist for this index. Because there is no
definite evidence that MAP or PP was clearly superior to
DBP and SBP, the 2 former measures do not need to be
incorporated into future guidelines.32 Most clinicians think in
terms of SBP and DBP, and these 2 measures remain
important and clinically useful. However, these data suggest
that if time or resources are highly constrained, such as in
much-needed epidemiologic surveys in developing countries,
very little is lost from measuring only SBP.
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